Stanley Chan

Guest Editor for the following articles:

Vol. 31. No. 2

Cutting Edge in Medical Management of Cutaneous Oncology

Adil Daud, MD | Kim Chong, MD | Sarah T Arron, MD, PhD

Traditional chemotherapy has resulted in only a modest response, if any, for the 3 most
common cutaneous malignancies of basal cell carcinoma, squamous cell carcinoma, and
melanoma. Recent advances in understanding of the defects in the pathways driving
tumorigenesis have changed the way that we think of these cancers and paved the way
to targeted therapy for specific tumors. In this review, we will introduce the novel
systemic treatments currently available for these cancers in the context of what is
understood about the tumor pathogenesis. We will also introduce ongoing studies that
will hopefully broaden our options for highly effective and tolerable treatment.
Semin Cutan Med Surg 31:140-149 © 2012 Elsevier Inc. All rights reserved.